By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Auspex Pharmaceuticals 

1261 Liberty Way
Suite C
Vista  California  92081-8356  U.S.A.
Phone: 760-599-1800 Fax: 760-599-1801



Company News
SoCal's Auspex Pharmaceuticals (ASPX) Soars 90% On Huntington's Disease Drug Trial Data 12/17/2014 6:35:46 AM
Auspex Pharmaceuticals To Present At The Piper Jaffray Healthcare Conference 12/4/2014 3:45:40 PM
Auspex Pharmaceuticals Reports Third Quarter 2014 Results And Business Highlights 11/10/2014 7:56:19 AM
Auspex Pharmaceuticals Receives FDA Orphan Drug Designation Of SD-809 For Treatment Of Huntington's Disease 11/6/2014 11:23:03 AM
Auspex Pharmaceuticals Initiates Second Pivotal Clinical Trial For SD-809 In Tardive Dyskinesia 10/30/2014 7:56:25 AM
Auspex Pharmaceuticals To Present At The Baird 2014 Healthcare Conference 8/28/2014 7:26:29 AM
Auspex Pharmaceuticals Completes Enrollment In Phase 3 Registration Clinical Trial Of SD-809 In Chorea Associated With Huntington's Disease 8/18/2014 7:03:33 AM
Auspex Pharmaceuticals Reports Second Quarter 2014 Results 8/8/2014 7:39:58 AM
Auspex Pharmaceuticals Initiates Pivotal Phase 2/3 Clinical Trial For SD-809 In Tardive Dyskinesia 7/17/2014 6:41:54 AM
Auspex Pharmaceuticals Announces Completion Of Follow On Offering And Exercise Of Underwriters' Option To Purchase Additional Shares 7/17/2014 6:02:51 AM